Manulife (Manufacturers Life Insurance)
SRNE

Manulife (Manufacturers Life Insurance)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-149,477
Closed -$132K – 3009
2022
Q4 		$132K Buy
149,477
+8,039
+6% +$10.7K ﹤0.01% 2718
2022
Q3 		$222K Sell
141,438
-3,126
-2% -$7.09K ﹤0.01% 2517
2022
Q2 		$291K Buy
144,564
+28,906
+25% +$50K ﹤0.01% 2419
2022
Q1 		$269K Sell
115,658
-27,594
-19% -$86.1K ﹤0.01% 2578
2021
Q4 		$666 Buy
143,252
+5,360
+4% +$33.3K ﹤0.01% 2078
2021
Q3 		$1.05M Sell
137,892
-9,858
-7% -$83.6K ﹤0.01% 1809
2021
Q2 		$1.43M Buy
147,750
+12,296
+9% +$97.9K ﹤0.01% 1777
2021
Q1 		$1.12M Sell
135,454
-8,449
-6% -$89.2K ﹤0.01% 1812
2020
Q4 		$982K Buy
143,903
+21,579
+18% +$173K ﹤0.01% 1822
2020
Q3 		$1.36M Buy
122,324
+21,505
+21% +$197K ﹤0.01% 1542
2020
Q2 		$616K Buy
100,819
+20,903
+26% +$80K ﹤0.01% 1848
2020
Q1 		$147K Buy
79,916
+5,514
+7% +$15.9K ﹤0.01% 2454
2019
Q4 		$251K Sell
74,402
-1,385
-2% -$3.3K ﹤0.01% 2446
2019
Q3 		$164K Buy
75,787
+3,366
+5% +$7.84K ﹤0.01% 2676
2019
Q2 		$193K Sell
72,421
-3,297
-4% -$11.9K ﹤0.01% 2670
2019
Q1 		$360K Buy
75,718
+6,411
+9% +$16.8K ﹤0.01% 2205
2018
Q4 		$166K Sell
69,307
-1,556
-2% -$5.08K ﹤0.01% 2366
2018
Q3 		$312K Buy
70,863
+7,748
+12% +$43K ﹤0.01% 2528
2018
Q2 		$454K Buy
+63,115
New +$429K ﹤0.01% 2474
2017
Q2 		– Sell
-21,537
Closed -$85K – 4488
2017
Q1 		$85K Buy
21,537
+1,918
+10% +$9.62K ﹤0.01% 3244
2016
Q4 		$96K Sell
19,619
-756
-4% -$4.54K ﹤0.01% 3243
2016
Q3 		$158K Sell
20,375
-531
-3% -$3.58K ﹤0.01% 2947
2016
Q2 		$118K Buy
20,906
+1,753
+9% +$11.2K ﹤0.01% 3145
2016
Q1 		$100K Buy
19,153
+746
+4% +$4.34K ﹤0.01% 3043
2015
Q4 		$160 Buy
18,407
+476
+3% +$4.01K ﹤0.01% 2820
2015
Q3 		$151 Buy
17,931
+333
+2% +$5.3K ﹤0.01% 2884
2015
Q2 		$310 Buy
+17,598
New +$226K ﹤0.01% 2484

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SRNE Position: Q1 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 149,477 shares — an estimated $132K sold.

Manulife (Manufacturers Life Insurance) first reported a position in SRNE in Q2 2015 and held it in 27 quarters. The position peaked at $1.43M in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 149,477 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $132K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 27 quarters.
  • Manulife (Manufacturers Life Insurance)'s Sorrento Therapeutics, Inc. position peaked at $1.43M in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2023, filed 15 May 2023.